Literature DB >> 27272934

ABPM Induced Alarm Reaction: A Possible Cause of Overestimation of Daytime Blood Pressure Values Reduced By Treatment with Beta-Blockers.

Francesco Salvo1, Chiara Lonati2, Monica Albano3, Paolo Fogliacco3, Andrea Riccardo Errani3, Cinzia Vallo3, Michele Berardi3, Vito Meinero3, Carlo Lorenzo Muzzulini3, Alberto Morganti4.   

Abstract

INTRODUCTION: Alarm reaction to clinical blood pressure (BP) measurement, defined white-coat effect (WCE), can cause overestimation of true BP values. AIM: To assess whether ambulatory blood pressure monitoring (ABPM) can similarly affect BP values during the initial hours of recording.
METHODS: In 420 ABPMs selected for a first systolic BP (SBP) reading at least 10 mmHg higher than the mean daytime SBP, we calculated mean diurnal and 24 h SBP with and without the exclusion of the two first hours of recording defined as the WCE window (WCEw). We also calculated the magnitude and duration of WCE. These analyses were also performed separately in patients off anti-hypertensive treatment (n = 156), and on treatment with and without the inclusion of beta-blockers (respectively n = 113 and 151).
RESULTS: Exclusion of WCEw period reduced mean diurnal and 24 h SBP respectively from 135 ± 0.5 to 133 ± 0.5 (p < 0.01) and from 131 ± 0.5 to 130 ± 0.5 (p < 0.02). As a result the percentage of patients diagnosed as having diurnal or 24 h hypertension was reduced respectively from 48 to 40 % and from 52 to 47 %. The magnitude of WCEw was similar in both genders but the duration was longer in females (66 ± 2 vs. 56 ± 2 min, p < 0.01). Treatment with beta-blockers was associated with a shorter duration of WCE in both genders but this effect was statistically significant only in males.
CONCLUSIONS: In some patients ABPM is not free from WCE. WCE may affect the overall estimation of BP profile and is longer but less blunted by beta-blockers in females than in males.

Entities:  

Keywords:  Alarm reaction; Ambulatory blood pressure monitoring; Beta-blockers; White-coat effect

Mesh:

Substances:

Year:  2016        PMID: 27272934     DOI: 10.1007/s40292-016-0161-4

Source DB:  PubMed          Journal:  High Blood Press Cardiovasc Prev        ISSN: 1120-9879


  20 in total

1.  European Society of Hypertension position paper on ambulatory blood pressure monitoring.

Authors:  Eoin O'Brien; Gianfranco Parati; George Stergiou; Roland Asmar; Laurie Beilin; Grzegorz Bilo; Denis Clement; Alejandro de la Sierra; Peter de Leeuw; Eamon Dolan; Robert Fagard; John Graves; Geoffrey A Head; Yutaka Imai; Kazuomi Kario; Empar Lurbe; Jean-Michel Mallion; Giuseppe Mancia; Thomas Mengden; Martin Myers; Gbenga Ogedegbe; Takayoshi Ohkubo; Stefano Omboni; Paolo Palatini; Josep Redon; Luis M Ruilope; Andrew Shennan; Jan A Staessen; Gert vanMontfrans; Paolo Verdecchia; Bernard Waeber; Jiguang Wang; Alberto Zanchetti; Yuqing Zhang
Journal:  J Hypertens       Date:  2013-09       Impact factor: 4.844

2.  White-coat and masked hypertension are associated with carotid atherosclerosis in a general population: the Hisayama study.

Authors:  Masayo Fukuhara; Hisatomi Arima; Toshiharu Ninomiya; Jun Hata; Yoichiro Hirakawa; Yasufumi Doi; Koji Yonemoto; Naoko Mukai; Masaharu Nagata; Fumie Ikeda; Kiyoshi Matsumura; Takanari Kitazono; Yutaka Kiyohara
Journal:  Stroke       Date:  2013-05-02       Impact factor: 7.914

3.  How common is white coat hypertension?

Authors:  T G Pickering; G D James; C Boddie; G A Harshfield; S Blank; J H Laragh
Journal:  JAMA       Date:  1988-01-08       Impact factor: 56.272

Review 4.  White-coat hypertension, as defined by ambulatory blood pressure monitoring, and subclinical cardiac organ damage: a meta-analysis.

Authors:  Cesare Cuspidi; Marta Rescaldani; Marijana Tadic; Carla Sala; Guido Grassi; Giuseppe Mancia
Journal:  J Hypertens       Date:  2015-01       Impact factor: 4.844

Review 5.  White-coat hypertension and cardiovascular events: a meta-analysis.

Authors:  Alexandros Briasoulis; Emmanuel Androulakis; Mohan Palla; Nikolaos Papageorgiou; Dimitris Tousoulis
Journal:  J Hypertens       Date:  2016-04       Impact factor: 4.844

6.  Incidence of cardiovascular events in white-coat, masked and sustained hypertension versus true normotension: a meta-analysis.

Authors:  Robert H Fagard; Véronique A Cornelissen
Journal:  J Hypertens       Date:  2007-11       Impact factor: 4.844

7.  Prognosis of white-coat and masked hypertension: International Database of HOme blood pressure in relation to Cardiovascular Outcome.

Authors:  George S Stergiou; Kei Asayama; Lutgarde Thijs; Anastasios Kollias; Teemu J Niiranen; Atsushi Hozawa; José Boggia; Jouni K Johansson; Takayoshi Ohkubo; Ichiro Tsuji; Antti M Jula; Yutaka Imai; Jan A Staessen
Journal:  Hypertension       Date:  2014-01-13       Impact factor: 10.190

8.  White coat effect in treated hypertensive patients: sex differences.

Authors:  M G Myers; R A Reeves
Journal:  J Hum Hypertens       Date:  1995-09       Impact factor: 3.012

9.  White-coat and masked hypertension as risk factors for progression to sustained hypertension: the Finn-Home study.

Authors:  Sam S E Sivén; Teemu J Niiranen; Ilkka M Kantola; Antti M Jula
Journal:  J Hypertens       Date:  2016-01       Impact factor: 4.844

10.  Age-specific differences between conventional and ambulatory daytime blood pressure values.

Authors:  David Conen; Stefanie Aeschbacher; Lutgarde Thijs; Yan Li; José Boggia; Kei Asayama; Tine W Hansen; Masahiro Kikuya; Kristina Björklund-Bodegård; Takayoshi Ohkubo; Jørgen Jeppesen; Yu-Mei Gu; Christian Torp-Pedersen; Eamon Dolan; Tatiana Kuznetsova; Katarzyna Stolarz-Skrzypek; Valérie Tikhonoff; Tobias Schoen; Sofia Malyutina; Edoardo Casiglia; Yuri Nikitin; Lars Lind; Edgardo Sandoya; Kalina Kawecka-Jaszcz; Luis Mena; Gladys E Maestre; Jan Filipovský; Yutaka Imai; Eoin O'Brien; Ji-Guang Wang; Lorenz Risch; Jan A Staessen
Journal:  Hypertension       Date:  2014-09-02       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.